196 related articles for article (PubMed ID: 20408881)
1. Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression.
Shaker ME; Salem HA; Shiha GE; Ibrahim TM
Fundam Clin Pharmacol; 2011 Apr; 25(2):248-57. PubMed ID: 20408881
[TBL] [Abstract][Full Text] [Related]
2. Comparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosis.
Shaker ME; Shiha GE; Ibrahim TM
Eur J Pharmacol; 2011 Nov; 670(2-3):593-600. PubMed ID: 21925495
[TBL] [Abstract][Full Text] [Related]
3. Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis.
Shaker ME; Zalata KR; Mehal WZ; Shiha GE; Ibrahim TM
Toxicol Appl Pharmacol; 2011 Apr; 252(2):165-75. PubMed ID: 21316382
[TBL] [Abstract][Full Text] [Related]
4. Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.
Shiha GE; Abu-Elsaad NM; Zalata KR; Ibrahim TM
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):788-97. PubMed ID: 25115651
[TBL] [Abstract][Full Text] [Related]
5.
Yang HY; Kim KS; Lee YH; Park JH; Kim JH; Lee SY; Kim YM; Kim IS; Kacew S; Lee BM; Kwak JH; Yoon K; Kim HS
Int J Biol Sci; 2019; 15(4):800-811. PubMed ID: 30906211
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats.
Ibrahim SA; Mohamed MZ; El-Tahawy NF; Abdelrahman AM
Can J Physiol Pharmacol; 2021 Mar; 99(3):313-320. PubMed ID: 32721217
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats.
Lee YH; Son JY; Kim KS; Park YJ; Kim HR; Park JH; Kim KB; Lee KY; Kang KW; Kim IS; Kacew S; Lee BM; Kim HS
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362375
[TBL] [Abstract][Full Text] [Related]
8. Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats.
Elnfarawy AA; Nashy AE; Abozaid AM; Komber IF; Elweshahy RH; Abdelrahman RS
Hum Exp Toxicol; 2021 Feb; 40(2):355-368. PubMed ID: 32840391
[TBL] [Abstract][Full Text] [Related]
9. Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway.
El-Fadaly AA; Afifi NA; El-Eraky W; Salama A; Abdelhameed MF; El-Rahman SSA; Ramadan A
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):355-366. PubMed ID: 35255766
[TBL] [Abstract][Full Text] [Related]
10. Anti-fibrotic effects of Cuscuta chinensis with in vitro hepatic stellate cells and a thioacetamide-induced experimental rat model.
Kim JS; Koppula S; Yum MJ; Shin GM; Chae YJ; Hong SM; Lee JD; Song M
Pharm Biol; 2017 Dec; 55(1):1909-1919. PubMed ID: 28651481
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone protects thioacetamide-induced chronic liver injury by inhibiting TGF-β1/Smad3 axis in rats.
Raghunandhakumar S; Ezhilarasan D; Shree Harini K
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23694. PubMed ID: 38504479
[TBL] [Abstract][Full Text] [Related]
12. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate.
Kim Y; Fiel MI; Albanis E; Chou HI; Zhang W; Khitrov G; Friedman SL
Liver Int; 2012 Jul; 32(6):1008-17. PubMed ID: 22507133
[TBL] [Abstract][Full Text] [Related]
13. Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats.
Ramadan A; Afifi N; Yassin NZ; Abdel-Rahman RF; Abd El-Rahman SS; Fayed HM
Chem Biol Interact; 2018 Jun; 289():109-118. PubMed ID: 29738702
[TBL] [Abstract][Full Text] [Related]
14. Effect of carnosine against thioacetamide-induced liver cirrhosis in rat.
Aydin AF; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Güllüoğlu M; Uysal M; Koçak-Toker N
Peptides; 2010 Jan; 31(1):67-71. PubMed ID: 19958806
[TBL] [Abstract][Full Text] [Related]
15. Protective role of antioxidants on thioacetamide-induced acute hepatic encephalopathy: biochemical and ultrastructural study.
Mustafa HN; El Awdan SA; Hegazy GA
Tissue Cell; 2013 Oct; 45(5):350-62. PubMed ID: 23876406
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.
Shirin H; Sharvit E; Aeed H; Gavish D; Bruck R
World J Gastroenterol; 2013 Jan; 19(2):241-8. PubMed ID: 23345947
[TBL] [Abstract][Full Text] [Related]
17. Melatonin mitigates thioacetamide-induced hepatic fibrosis via antioxidant activity and modulation of proinflammatory cytokines and fibrogenic genes.
Lebda MA; Sadek KM; Abouzed TK; Tohamy HG; El-Sayed YS
Life Sci; 2018 Jan; 192():136-143. PubMed ID: 29180002
[TBL] [Abstract][Full Text] [Related]
18. Quercetin ameliorates thioacetamide-induced hepatic fibrosis and oxidative stress by antagonizing the Hedgehog signaling pathway.
Aslam A; Sheikh N; Shahzad M; Saeed G; Fatima N; Akhtar T
J Cell Biochem; 2022 Aug; 123(8):1356-1365. PubMed ID: 35696520
[TBL] [Abstract][Full Text] [Related]
19. Sidr honey abrogates the oxidative stress and downregulates the hyaluronic acid concentration and gene expression of TGF-β1 and COL1a1 in rat model of thioacetamide-induced hepatic fibrosis.
Zeweil MM; Sadek KM; Elsadek MF; Mahmoud SF; Ahmed BM; Khafaga AF
Anim Sci J; 2020; 91(1):e13434. PubMed ID: 32696560
[TBL] [Abstract][Full Text] [Related]
20. Dendropanoxide Alleviates Thioacetamide-induced Hepatic Fibrosis via Inhibition of ROS Production and Inflammation in BALB/
Kundu A; Gali S; Sharma S; Kacew S; Yoon S; Jeong HG; Kwak JH; Kim HS
Int J Biol Sci; 2023; 19(9):2630-2647. PubMed ID: 37324954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
